Ozawa Hiroyuki, Saitou Hideyuki, Mizutari Kunio, Takata Yasunori, Ogawa Kaoru
Department of Otolaryngology, Keio University School of Medicine, Tokyo, Japan.
Am J Otolaryngol. 2007 Jan-Feb;28(1):46-9. doi: 10.1016/j.amjoto.2006.06.011.
We report on 2 cases of hypothyroidism presenting clinical symptoms that occurred after radiotherapy for cancer of the head and neck and on the results of estimating thyroid function in patients with head and neck cancer who received radiotherapy. The first patient underwent total laryngectomy for laryngeal cancer without sacrificing the thyroid gland and partial gastrectomy for gastric cancer. Radiotherapy of the neck was carried out postoperatively. Two years later, the patient developed chest pain; pericardial effusion was detected, leading to a diagnosis of myxedema caused by hypothyroidism. The second patient received radiotherapy alone for laryngeal cancer. Two months later, low serum sodium concentration and anemia were detected in this patient. The cause of these changes was subsequently found to be hypothyroidism. Based on our experience with these 2 cases, we measured thyroid function in 35 patients who had undergone neck radiation for head and neck cancer at our hospital over the past 10 years. Hypothyroidism was observed in 13 of the 35 patients (37%). The prevalence of hypothyroidism was 46% (6/13) for patients treated with both radiation and surgery, as compared with 32% (7/22) for those who received radiation alone. The risk factors responsible for hypothyroidism were not evident from the statistical analysis of these cases. We believe that thyroid function should be evaluated periodically in patients who have undergone neck radiation because it is often difficult to diagnose hypothyroidism only from clinical symptoms.
我们报告了2例头颈部癌放疗后出现临床症状的甲状腺功能减退病例,以及对头颈部癌接受放疗患者的甲状腺功能评估结果。首例患者因喉癌接受全喉切除术,未切除甲状腺,后因胃癌接受部分胃切除术。术后对颈部进行了放疗。两年后,患者出现胸痛;检测到心包积液,诊断为甲状腺功能减退所致黏液性水肿。第二例患者仅因喉癌接受放疗。两个月后,该患者检测到低血钠浓度和贫血。这些变化的原因随后被发现是甲状腺功能减退。基于我们对这2例病例的经验,我们对我院过去10年中因头颈部癌接受颈部放疗的35例患者进行了甲状腺功能检测。35例患者中有13例(37%)出现甲状腺功能减退。接受放疗和手术治疗的患者中甲状腺功能减退的患病率为46%(6/13),而仅接受放疗的患者中这一比例为32%(7/22)。从这些病例的统计分析中,导致甲状腺功能减退的危险因素并不明显。我们认为,对接受颈部放疗的患者应定期评估甲状腺功能,因为仅根据临床症状往往难以诊断甲状腺功能减退。